Total liabilities · 2016–2025
Ascendis Pharma total liabilities
$1.7B+29.0% · FY2025
Ascendis Pharma (ASND) reported $1.7B in total liabilities for fiscal 2025, +29.0% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.7B | +29.0% | Open → |
| FY20242024-12-31 | $1.3B | +24.4% | Open → |
| FY20232023-12-31 | $1.1B | +21.8% | Open → |
| FY20222022-12-31 | $881M | +286.6% | Open → |
| FY20212021-12-31 | $228M | +31.7% | Open → |
| FY20202020-12-31 | $173M | +93.6% | Open → |
| FY20192019-12-31 | $89.4M | +100.7% | Open → |
| FY20182018-12-31 | $44.6M | +56.3% | Open → |
| FY20172017-12-31 | $28.5M | +100.9% | Open → |
| FY20162016-12-31 | $14.2M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +70.4%
Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ascendis Pharma total liabilities |url=https://companiesranked.com/en/company/ascendis-pharma/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ascendis Pharma total liabilities. CompaniesRanked. https://companiesranked.com/en/company/ascendis-pharma/total-liabilitiesBibTeX
@misc{companiesranked-en-company-ascendis-pharma-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Ascendis Pharma total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ascendis-pharma/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-046590 · February 11, 2026
{{cite web |title=Ascendis Pharma total liabilities — 20-F (0001193125-26-046590) |url=https://www.sec.gov/Archives/edgar/data/1612042/000119312526046590/asnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-11}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.